Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)
Clinical trial NCT01894516 · COMPLETED
Trial details
- NCT number
- NCT01894516
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-08
- Primary completion
- 2015-03-05
- Enrollment
- 287
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.